Blockchain Concepts Emerge in Clinical Trials
In this interview, Munther Baara, Head of New Clinical Paradigms at Pfizer, will discuss his perspectives on how blockchain may impact clinical trials.
Clinical Trials Don't Have to Cost Too Much or Take Too Long
A discussion of the cost and time put into clinical trials.
Monoclonal Antibodies: Clinical Pharmacology Knowledge in Support of FIH and Early Development
There are several pharmacokinetic factors and peculiarities that should be considered carefully when designing and running first-in-human (FIH) studies for monoclonal antibodies.
MMS Partners with University of Findlay to Provide Medical Writing and Clinical Trial Disclosure Courses
MMS Partners with University of Findlay
Oncology Therapy-Focused RACT Emerges
Newest revelations suggest Risk Assessment Categorization Tools are now becoming therapeutic area-specific, as an oncology-based risk library is now surfacing.
BMS and Biomarker Research: An Interview with Saurabh Saha
BMS executive shares his perspectives on the current biomarker landscape, the role of translational medicine in accelerating this area of study, and how BMS is working to advance biomarker research across their R&D portfolio.
"Right-to-Try" Scope Expanding to Europe?
Peter O’Donnell explores potential parallels of the U.S. “right-to-try” debate in Europe.
Maximizing Immuno-Oncology Clinical Trial Success
Examining the unique standards and related challenges when assessing the safety and efficacy of cancer immunotherapy candidates.
Applied Clinical Trials, May 2018 Issue (PDF)
Click the title above to open the Applied Clinical Trials May 2018 issue in an interactive PDF format.
Syneos Health Launches Catalyst Ophthalmology Site Network to Support Faster Start Up and Efficient Trial Delivery
Syneos Health Launches Catalyst Ophthalmology Site Network
Belgium Draws a Clear Line on "Right-to-Try"–and Backs Research Independence
An additional light has been shone on the "right-to-try" debate in Europe by a strongly-worded statement from Belgium's feisty health minister, Maggie De Block.
Dubious UK Promises on Post-Brexit Clinical Trials
The British government continues to offer guarantees and reassurances about the post-Brexit future of its life-sciences sector despite the obvious failure so far to get even close to negotiating a withdrawal agreement with the EU.
Novartis Launches FocalView app
University of Texas System Initiative, Clinical Trials Xpress (CTX), Named as a PAREXEL Strategic Site Alliance Network Member
Novartis Launches FocalView app, Providing Opportunity for Patients to Participate in Ophthalmology Clinical Trials from Home
Clinical Trials Xpress, Named as a PAREXEL Strategic Site Alliance Network Member
ClinicalStudyDataRequest.com Announces Partnerships with Global Academic Research Funders to Expand Researchers’ Access to Patient-level Clinical Trial Data
ClinicalStudyDataRequest.com Announces Partnerships with Global Academic Research Funders
Risk Based Budgeting
Adoption of the concept of Risk-Based Budgeting could help maintain the trial budget or even save the whole clinical trial.
FDA Examines Eligibility Criteria in Clinical Trial Design and Product Development
Recent legislation authorizes further assessment of FDA eligibility policies and of NIH research standards.
New Release of Cenduit’s IRT Platform and Quantum Interactive
New Release of Cenduit’s IRT Platform and Quantum Interactive Updates Enable Efficient Technology Transfer and Increased Reports Customization for Clinical Trials
CRF Health’s TrialMax eCOA Solution Selected for Landmark Pain Outcomes Study by Global Japanese Pharmaceutical Company
CRF Health’s TrialMax eCOA Solution Selected for Landmark Pain Outcomes Study
Topstone Research Selects OmniComm’s TrialMaster EDC
OmniComm's TrialMaster EDC Selected by Topstone Research
Why Cash (and Checks) Aren’t King in Phase I Trials
The adoption of automated payment methods for phase I trials will allow for more effective clinical trials.
Synteract Repositions Itself with Centers of Therapeutic Development and Unveils Updated Brand Platform
